Klinikum Westmuensterland GmbH
- Address
- Wuellener Strasse 101, 48683 Ahaus, Germany
Calcific Aortic Valve Stenosis
The site focuses on calcific aortic valve stenosis, a leading cause of valve disease in older adults. Ongoing studies aim to assess whether lowering lipoprotein(a) can slow disease progression and improve heart function.
- Evaluation of valve narrowing using echocardiography
- Assessment of calcium buildup with computed tomography
- Impact of novel lipid‑targeting therapy on disease trajectory
These investigations support the broader goal of reducing the burden of cardiovascular disease in patients with high risk profiles.
Hypertension and Cardiovascular Risk
Research at Klinikum Westmuensterland addresses uncontrolled hypertension and its link to heart attacks, strokes, and heart failure. A trial evaluates a new RNA‑based treatment to lower cardiovascular events in patients with established disease or elevated risk.
- Monitoring of blood pressure control
- Tracking incidence of myocardial infarction, stroke, and heart failure hospitalizations
- Comparison of treatment versus placebo on overall cardiovascular outcomes
The work aligns with the institution’s commitment to improving prevention and management of cardiovascular disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Alnylam Pharmaceuticals Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikum Westmuensterland GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS] | Novartis Pharma AG | Phase II | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 1 | Unknown | 2025-12-10 | 2025-12-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.